A detailed history of Trifecta Capital Advisors, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Trifecta Capital Advisors, LLC holds 914 shares of ZTS stock, worth $161,814. This represents 0.04% of its overall portfolio holdings.

Number of Shares
914
Previous 914 -0.0%
Holding current value
$161,814
Previous $158 Million 12.7%
% of portfolio
0.04%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 01, 2023

BUY
$167.14 - $192.77 $16,714 - $19,277
100 Added 12.29%
914 $159 Million
Q1 2023

May 09, 2023

BUY
$145.48 - $175.02 $116,383 - $140,016
800 Added 5714.29%
814 $135 Million
Q4 2022

Jan 17, 2023

BUY
$131.14 - $157.47 $1,835 - $2,204
14 New
14 $2.05 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.9B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Trifecta Capital Advisors, LLC Portfolio

Follow Trifecta Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trifecta Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trifecta Capital Advisors, LLC with notifications on news.